4.5 Article

Comparative Evaluation of Estrogen and Progesterone Receptor Expression With Connexins 26 and 43 in Endometrial Cancer

Journal

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume 19, Issue 7, Pages 1253-1257

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1111/IGC.0b013e3181a40618

Keywords

Connexin 26; Connexin 43; Estrogen receptor; Progesterone receptor; Endometrial cancer; Immunohistochemistry

Ask authors/readers for more resources

Progression of numerous neoplasms could involve alterations of gap junction channels composed of connexins (Cxs). Disorders of expression and cellular displacement of Cxs were also found in endometrial cancer. Gap junctional intercellular communication can be regulated by wide array of agents, for instance, growth factors, oncogenes, and steroid hormones. Nevertheless, expressions of Cxs and progesterone receptor (PR) were not compared in human tissues. This study focused oil assessment of expression of estrogen receptor alpha (ER alpha) and PRs in relation to the expression of Cx26 and Cx43 in 88 cases of endometrial cancer and analysis of these proteins' expression in comparison with anatomoclinical features. Positive ER(x and PR nuclear staining was present in 66 (75%) and 60 (68.2%) of all studied tumors, respectively. Positive correlation was found between expression of PR and histopathologic type of tumor (P = 0.026), and negative correlation was drawn with grading (G) (P = 0.002). There were positive reactions to Cx26 and Cx43 of mainly cytoplasmic location in 60 (68.2%) and 66 (75%) of studied cancers, respectively. Progesterone receptor expression correlated negatively with Cx26 in endometrial cancers (P = 0.016, r = -0.256). Moreover, ER alpha expression positively correlated with PR expression (P < 0.001, r = 0.678). On the ground Of Our findings, disorders of Cx expression and altered distribution pattern occur during endometrial carcinogenesis, and it seems that PR Could participate in this fact. Loss of functional gap junctions may occur because of the aberrant expression and localization of Cx26 and Cx43 in endometrial cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available